The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion
doi: 10.1038/nchembio.1681 295 Vakifahmetoglu-NorbergHXiaHYuanJ
Behavior in acidic environments In the literature about classic BPC-157, it has been repeatedly emphasized that the peptide is stable in human gastric juice
Remember, the key to seeing real progress is consistency in both your peptide use and your workouts
Getting your peptide through a means your BPC-157 comes from licensed US-based 503A pharmacies that meet all of these standards
FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss